MN Services Vermogensbeheer
ALNY icon

MN Services Vermogensbeheer’s Alnylam Pharmaceuticals ALNY Stock Holding History

MN Services Vermogensbeheer’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.5M Hold
38,700
– – 0.07% 231
2026
Q2 		$11.6M Buy
+38,700
New +$11.7M 0.09% 209
2019
Q3 		– Sell
-15,400
Closed -$1.12M – 355
2019
Q2 		$1.12M Hold
15,400
– – 0.01% 612
2019
Q1 		$1.44M Hold
15,400
– – 0.02% 555
2018
Q4 		$982K Buy
15,400
+100
+0.7% +$7.69K 0.01% 563
2018
Q3 		$1.34M Buy
15,300
+1,500
+11% +$151K 0.03% 551
2018
Q2 		$1.36M Hold
13,800
– – 0.03% 541
2018
Q1 		$1.64M Hold
13,800
– – 0.04% 473
2017
Q4 		$1.46M Buy
+13,800
New +$1.73M 0.05% 442
2016
Q4 		– Sell
-1,974
Closed -$134K – 623
2016
Q3 		$134K Buy
1,974
+87
+5% +$6.14K 0.03% 569
2016
Q2 		$94K Hold
1,887
– – 0.02% 595
2016
Q1 		$104K Buy
+1,887
New +$125K 0.02% 622

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

MN Services Vermogensbeheer's ALNY Position: Q3 2026 in Review

MN Services Vermogensbeheer held its Alnylam Pharmaceuticals (ALNY) position steady in Q3 2026 at 38,700 shares worth $9.5M. The position accounts for 0.07% of the portfolio, ranked #231.

MN Services Vermogensbeheer first reported a position in ALNY in Q1 2016 and has held it in 12 quarters since. The position peaked at $11.6M in Q2 2026. 591 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.

  • MN Services Vermogensbeheer held 38,700 shares of Alnylam Pharmaceuticals worth $9.5M as of Q3 2026.
  • MN Services Vermogensbeheer left its Alnylam Pharmaceuticals share count unchanged in Q3 2026.
  • Alnylam Pharmaceuticals made up 0.07% of MN Services Vermogensbeheer's portfolio in Q3 2026, its #231 holding.
  • MN Services Vermogensbeheer first reported a position in Alnylam Pharmaceuticals in Q1 2016 and has held it in 12 quarters since.
  • MN Services Vermogensbeheer's Alnylam Pharmaceuticals position peaked at $11.6M in Q2 2026.
  • 591 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.

Based on MN Services Vermogensbeheer's 13F filing for Q3 2026, filed 8 Oct 2026.